Pharming Group Shareholders Approve Key Proposals
Has released an update. Pharming Group N.V. reports a successful Annual General Meeting where shareholders approved key propo...
Source: biztoc.com
📰 Pharming Group News
Page 2 - Pharming Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharming Group. Real-time updates on events, politics, business and more.
Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF BONDHOLDERS. IF BONDHOLDERS ARE IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD SEEK THEIR OWN FINANCIAL AND LEGAL ADVICE...
Source: marketscreener.com
Pharming N : Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 - Form 6-K
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
Source: marketscreener.com
Pharming Group's Strategic Financial Maneuver
Has released an update. Pharming Group N.V. has announced the launch of a new €100 million convertible bond offering due 2...
Source: biztoc.com
Pharming N : to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards - Form 6-K
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
Source: marketscreener.com
Pharming Group to report first quarter 2024 financial
Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary...
Noord Holland United Kingdom City Of United States Michael Levitan Pharming Groupnv Euronext Amsterdam
Source: globenewswire.com
Pharming Group to report first quarter 2024 financial results on May 8
Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. confirms it will report its preliminary first quarter 2024 financial results, for the period ended March 31, on Wednesday, May 8, 2024. ...
Source: marketscreener.com
Pharming N : Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
Pharming Group N.V. Pharming Group N.V. Below you will find information from the register publication of inside information. The information has been...
Source: marketscreener.com
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
Recognition given for achievement in commercializing Joenja® , a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the Netherlands,...
Source: marketscreener.com
Pharming Group Lauded for Rare Disease Treatment
Has released an update. Pharming Group N.V. has been recognized as an Industry Innovator at the National Organization for ...
Source: biztoc.com